FindTrial
Sign In

Skin biopsy in patients with systemic diseases with skin lesions and a correlation of clinical diagnosis with the biopsy findings.

Skin Biopsy in the Context of Systemic Diseases and Histopathological Correlation: An Observational Prospective Study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/11/047362
Enrollment
98
Registered
2022-11-16
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

Intervention1: NIL: NIL

Sponsors

Dr Parul Gemnani
Lead Sponsor
Dr Sathish Pai B
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients with systemic diseases for whom a dermatological consultation is sought and a skin biopsy is advised by the treating dermatologist, and is performed for histopathological examination.

Exclusion criteria

Exclusion criteria: 1. Patients for whom a skin biopsy is performed for a primarily dermatological disease. 2. Inadequate skin biopsies. 3. Cases lacking a presumptive clinical diagnosis/ a definitive histopathological report.

Design outcomes

Primary

MeasureTime frame
Correlation between clinical and histopathological diagnosis of cutaneous lesions in systemic diseases.Timepoint: Correlation between clinical and histopathological diagnosis of cutaneous lesions in systemic diseases in patients enrolled in the study period 21 Nov 2022 to 20 April 2024.—

Secondary

MeasureTime frame
Most common cutaneous manifestations of systemic diseasesTimepoint: 21 Nov 2022 to 20 April 2024—

Countries

India

Contacts

Public ContactDr Parul Gemnani

Kasturba Medical College, Manipal

sb.pai@manipal.edu

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026